Sharathchandra S. Hegde, SVP, Research at Theravance Biopharma, Inc. (TBPH), sold 12,376 shares at $24.50 ($307K) on 2019-03-05, disclosed to the SEC on 2019-03-06.
Open-market sale of $307k TBPH by SVP, Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.06 | 3,343 | $84K | 27.3% |
| 2 | $25.06 | 3,343 | $84K | 27.3% |
| 3 | $24.50 | 5,690 | $139K | 45.4% |
| Total | $24.80 avg | 12,376 | $307K | 100% |